JP Morgan Private Wealth Advisors’s Forte Biosciences FBRX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48	Closed	-$197K	–	1405
2019 Q1	$197K	Hold	48	–	–	﹤0.01%	1377
2018 Q4	$149K	Hold	48	–	–	﹤0.01%	1370
2018 Q3	$282K	Hold	48	–	–	﹤0.01%	1328
2018 Q2	$170K	Buy	+48	New	+$176K	﹤0.01%	1388

Other funds holding FBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Private Wealth Advisors's FBRX Position: Q2 2019 in Review

JP Morgan Private Wealth Advisors sold out of Forte Biosciences (FBRX) in Q2 2019, closing a stake of 48 shares — an estimated $197K sold.

JP Morgan Private Wealth Advisors first reported a position in FBRX in Q2 2018 and held it in 4 quarters. The position peaked at $282K in Q3 2018. 74 funds tracked by Wall St. Rank hold FBRX as of Q2 2019.

JP Morgan Private Wealth Advisors reported no remaining Forte Biosciences position as of Q2 2019 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 48 Forte Biosciences shares in Q2 2019, an estimated $197K.
JP Morgan Private Wealth Advisors first reported a position in Forte Biosciences in Q2 2018 and held it in 4 quarters.
JP Morgan Private Wealth Advisors's Forte Biosciences position peaked at $282K in Q3 2018.
74 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.